Literature DB >> 16876511

Management of periocular basal and squamous cell carcinoma: a series of 485 cases.

Arie Y Nemet1, Yael Deckel, Peter A Martin, Georgina Kourt, Michael Chilov, Vidushi Sharma, Ross Benger.   

Abstract

PURPOSE: To analyze the outcome of management of patients with basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) in a tertiary referral eye center in Sydney, Australia.
DESIGN: Retrospective case series.
METHODS: Review of medical records of 485 consecutive cases (469 patients) with confirmed eyelid cancer. Intervention procedures: Surgical excision with 3- to 5-mm clinically clear margins and histologic confirmation of the surgical margins. Frozen section histology or Mohs' micrographic surgery (MMS) was used for incompletely excised cases, and those located in the medial canthus or close to the lacrimal drainage system. Standard reconstruction techniques were employed. MAIN OUTCOME MEASURES: Survival period free of tumor, incomplete excision, recurrences, type of closure, and complications.
RESULTS: Excision was initially incomplete in 25.4% of all tumors. Morpheaform type of BCC (chi(2)P < .001), and medial canthus location BCCs (chi(2)P < .05) were associated with a higher incomplete resection rate. A 35.9% incomplete excision rate was associated with a significantly higher recurrence rate compared with complete excision (8.4% and 4.6%, respectively, chi(2)P < .05). Twenty-seven patients (5.6%) had a recurrent tumor. After incomplete excision, there was no recurrence with MMS, but 4.7% recurrence rate when frozen section technique was used (P < .05). Local postoperative complications occurred in 41 patients (8.5%).
CONCLUSIONS: In the setting of a tertiary referral center, incomplete primary resection of an eyelid skin cancer is the main risk factor for recurrence. Incomplete resection is significantly associated with medial canthus location and morpheaform type of BCC and with moderately differentiated SCC. MMS is the safer technique after incomplete tumor excision.

Entities:  

Mesh:

Year:  2006        PMID: 16876511     DOI: 10.1016/j.ajo.2006.03.055

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  [Basal cell carcinoma of the periocular region].

Authors:  F Geszti; D Hargitai; O Lukáts; H Győrffy; J Tóth
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

2.  Malignant eyelid tumors: Are intra-operative rapid frozen section and permanent section diagnoses of surgical margins concordant?

Authors:  Swathi Kaliki; Sasi Pyda; Nupur Goel; Tarjani Vivek Dave; Milind N Naik; Dilip K Mishra
Journal:  Int Ophthalmol       Date:  2018-12-08       Impact factor: 2.031

Review 3.  Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma.

Authors:  Krishnamoorthy Narayanan; Omar H Hadid; Eric A Barnes
Journal:  Cochrane Database Syst Rev       Date:  2014-12-12

4.  Periocular basal cell carcinoma results and surgical outcome during a 5-year period in a larger Danish population.

Authors:  Sveina Björk Karlsdóttir; Simon Johannessen; Nikolaj Carsting Bjerrum; Ulrik Frydkjær-Olsen; Søren Leer Blindbæk; Flemming Møller; Camilla Wellejus
Journal:  BMC Ophthalmol       Date:  2022-06-28       Impact factor: 2.086

5.  Clinicopathological study of 21 cases of eyelid actinic keratosis.

Authors:  Elena López-Tizón; Enrique Mencía-Gutiérrez; María Garrido-Ruíz; Esperanza Gutiérrez-Díaz; Fernando López-Ríos
Journal:  Int Ophthalmol       Date:  2008-07-17       Impact factor: 2.031

6.  Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review.

Authors:  Courtney Crawford; Colby Fernelius; Paula Young; Stephen Groo; Darryl Ainbinder
Journal:  Clin Ophthalmol       Date:  2011-11-18

7.  The Importance of Frozen Section-Controlled Excision in Recurrent Basal Cell Carcinoma of the Eyelids.

Authors:  Berna Şahan; Ferda Çiftçi; Ferda Özkan; Vildan Öztürk
Journal:  Turk J Ophthalmol       Date:  2016-12-01

Review 8.  Management of high-risk and advanced basal cell carcinoma.

Authors:  S Puig; A Berrocal
Journal:  Clin Transl Oncol       Date:  2015-02-03       Impact factor: 3.405

9.  Histological and clinical features of primary and recurrent periocular Basal cell carcinoma.

Authors:  Guy J Ben Simon; Semion Lukovetsky; Fabio Lavinsky; Nahum Rosen; Mordechai Rosner
Journal:  ISRN Ophthalmol       Date:  2012-04-24

Review 10.  Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies.

Authors:  Louise Lansbury; Fiona Bath-Hextall; William Perkins; Wendy Stanton; Jo Leonardi-Bee
Journal:  BMJ       Date:  2013-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.